Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations

scientific article published on 01 December 1995

Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/HEP.1840220610
P698PubMed publication ID7489973

P2093author name stringMathieu D
Cherqui D
Rahmouni A
Charlotte F
Boulahdour H
Dhumeaux D
Fagniez PL
Zafrani ES
Meignan M
Métreau JM
P2860cites workSuperior staging of liver tumors with laparoscopy and laparoscopic ultrasoundQ24535519
Focal nodular hyperplasia of the liver: results of treatment and options in managementQ34393931
Complications of percutaneous abdominal fine-needle biopsy. ReviewQ37618268
Update on vascular tumours of the liverQ38606429
The fibrolamellar variant of hepatocellular carcinoma. Its association with focal nodular hyperplasiaQ39152349
Accumulation of technetium-99m sulfur colloid by hepatocellular adenoma: scintigraphic-pathologic correlationQ39508965
Liver-Cell Adenomas Associated with Use of Oral ContraceptivesQ39969798
Hepatic changes in young women ingesting contraceptive steroids. Hepatic hemorrhage and primary hepatic tumorsQ39974870
The histology of liver tumors in oral contraceptive users observed during a national survey by the American College of Surgeons Commission on cancerQ40265907
Complete regression of hepatocellular adenoma after withdrawal of oral contraceptivesQ42245312
Association of focal nodular hyperplasia and hepatic hemangiomaQ43421174
Focal nodular hyperplasia of the liver: assessment with contrast-enhanced TurboFLASH MR imagingQ44331220
Hepatocellular adenoma: color Doppler US and pathologic correlationsQ44600061
Fibrolamellar hepatocellular carcinoma: MR appearance.Q44863307
Possible association between benign hepatomas and oral contraceptivesQ50161055
On the pathogenesis of focal nodular hyperplasia of the liver.Q52264894
Transformation of hepatic cell adenoma to hepatocellular carcinoma due to oral contraceptive use.Q53516231
Focal Nodular Hyperplasia of the Liver and Intrahepatic Hemorrhage in Young Women on Oral ContraceptivesQ67320360
Regression of liver cell adenomas associated with oral contraceptivesQ67545167
Oral contraceptive-associated liver cell adenoma and hepatocellular carcinoma. Cytomorphology and mechanism of malignant transformationQ67694385
Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unitQ67967139
Focal nodular hyperplasia of the liver: MR imaging and pathologic correlation in 37 patientsQ68023737
Hepatic adenomas and focal nodular hyperplasia: dynamic CT studyQ68880605
Benign liver tumorsQ69336555
Focal nodular hyperplasia and hepatic adenoma: comparison of angiography, CT, US, and scintigraphyQ69901906
MR imaging of hepatic focal nodular hyperplasia: characterization and distinction from primary malignant hepatic tumorsQ70168482
Focal nodular hyperplasia of the liver: value of color Doppler US in association with MR imagingQ70604665
Resection of presumed benign liver tumoursQ70657616
Biopsy of focal hepatic lesions. Comparison of 18 and 22 gauge needlesQ71717615
Oral-contraceptive-associated liver tumours: occurrence of malignancy and difficulties in diagnosisQ72419125
Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma. A pilot studyQ72458530
Fibrolamellar carcinoma of the liver: A tumor of adolescents and young adults with distinctive clinico-pathologic featuresQ72855415
Hepatocellular carcinoma. Polygonal cell type with fibrous stroma—an atypical variant with a favorable prognosisQ72864882
P433issue6
P407language of work or nameEnglishQ1860
P921main subjecthepatocellular adenomaQ1172076
focal nodular hyperplasiaQ1435219
P304page(s)1674-1681
P577publication date1995-12-01
P1433published inHepatologyQ15724398
P1476titleManagement of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations
P478volume22

Reverse relations

cites work (P2860)
Q57648274Q57648274
Q33909761A case of hepatocellular carcinoma arising within large focal nodular hyperplasia with review of the literature
Q85616965A case of progressing focal nodular hyperplasia and its molecular expression pattern
Q48716774A cost-effectiveness analysis of the diagnostic strategies for differentiating focal nodular hyperplasia from hepatocellular adenoma
Q74577797A life-threatening complication of focal nodular hyperplasia
Q35056708Added value of Gd-EOB-DTPA-enhanced Hepatobiliary phase MR imaging in evaluation of focal solid hepatic lesions
Q37567380An unusual case of left hepatectomy for Focal Nodular Hyperplasia (FNH) linked to the use of Anabolic Androgenic Steroids (AASs).
Q33590285Application of dual phase imaging of 11C-acetate positron emission tomography on differential diagnosis of small hepatic lesions
Q42293542Approach of the patient with a liver mass
Q50646759Atypical focal nodular hyperplasia of the liver.
Q39413172Benign Neoplasms of the Liver
Q34162180Benign focal lesions of the liver
Q36042575Benign focal liver lesions: spectrum of findings on SonoVue-enhanced pulse-inversion ultrasonography
Q26748840Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma
Q36752231Benign liver lesions in female patients
Q26801185Benign liver tumors in pediatric patients - Review with emphasis on imaging features.
Q34162152Benign tumors of the liver
Q37262038Characteristics of common solid liver lesions and recommendations for diagnostic workup
Q36209810Concomitant hepatocellular adenoma and adenomatous hyperplasia in a patient without cirrhosis
Q47578466Contrast-enhanced ultrasound of focal nodular hyperplasia: a matter of size
Q35650424Current updates on the molecular genetics and magnetic resonance imaging of focal nodular hyperplasia and hepatocellular adenoma
Q36340220Diagnosis and management of hepatic focal nodular hyperplasia
Q38239629Differentiation of focal nodular hyperplasia from hepatocellular adenomas with low-mechanical-index contrast-enhanced sonography (CEUS): effect of size on diagnostic confidence.
Q57937931Drug induced hepatic focal nodular hyperplasia
Q49292129Efficacy comparison of multi-phase CT and hepatotropic contrast-enhanced MRI in the differential diagnosis of focal nodular hyperplasia: a prospective cohort study.
Q24243164Elective surgery for benign liver tumours
Q34247156Enzymatic activity of type 1 iodothyronine deiodinase in selected liver tumors
Q37231444European experience of 573 liver resections for hepatocellular adenoma: a cross-sectional study by the AFC-HCA-2013 study group
Q92265526Fluctuation of Hepatic Focal Nodular Hyperplasia Size with Oral Contraceptives Use
Q38117581Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management
Q77754360Focal nodular hyperplasia in a young female
Q37789970Focal nodular hyperplasia in children: clinical features and current management practice
Q63719417Focal nodular hyperplasia in normal and fatty liver: a qualitative and quantitative evaluation with contrast-enhanced ultrasound
Q33723588Focal nodular hyperplasia of the liver
Q82021774Focal nodular hyperplasia of the liver following hematopoietic SCT
Q35594682Focal nodular hyperplasia of the liver in men: is presentation the same in men and women?
Q86514591Focal nodular hyperplasia of the liver: an emerging complication of hematopoietic SCT in children
Q37940846Focal nodular hyperplasia--a review of myths and truths
Q37099044Focal nodular hyperplasia: characterisation at gadoxetic acid-enhanced MRI and diffusion-weighted MRI
Q39464803Focal nodular hyperplasia: our experience of 53 Japanese cases.
Q24673237Focal nodular hyperplasia: what are the indications for resection?
Q73598189Gadolinium-enhanced arterial-phase MR imaging of hypervascular liver tumors: comparison between tailored and fixed scanning delays in the same patients
Q49721825Growth of Focal Nodular Hyperplasia is Not a Reason for Surgical Intervention, but Patients Should be Referred to a Tertiary Referral Centre
Q36063314Hepatic adenomas in male patients
Q82640093Hepatic adenomas: presumed innocent until proven to be beta-catenin mutated
Q44464297Hepatic focal nodular hyperplasia in children previously treated for a solid tumor. Incidence, risk factors, and outcome
Q92573147Hepatocellular adenoma: An unsolved diagnostic enigma
Q61196686High prevalence of hepatic focal nodular hyperplasia in subjects with hereditary hemorrhagic telangiectasia
Q44109433Hypervascular hepatic lesions: dynamic and late enhancement pattern with Gd-BOPTA.
Q46469862Incidental focal solid liver lesions: diagnostic performance of contrast-enhanced ultrasound and MR imaging.
Q36426933Indication for treatment and long-term outcome of focal nodular hyperplasia
Q55365657Indications for liver surgery in benign tumours.
Q33181471Laparoscopic liver resections: a feasibility study in 30 patients
Q34585589Laparoscopic liver surgery: Shifting the management of liver tumors
Q33183376Laparoscopic living donor hepatectomy for liver transplantation in children
Q36063371Laparoscopic management of benign liver diseases: where are we?
Q36066052Liver cell adenoma and liver cell adenomatosis
Q37135975Liver cell adenoma showing sequential alteration of radiological findings suggestive of well-differentiated hepatocellular carcinoma
Q89459349Liver contrast-enhanced sonography: computer-assisted differentiation between focal nodular hyperplasia and inflammatory hepatocellular adenoma by reference to microbubble transport patterns
Q34588187Liver imaging. A surgeon's perspective
Q74375288Liver imaging. A surgeon's perspective
Q36063104Malignant transformation of hepatic adenoma with recurrence after resection
Q34383286Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases
Q28278138Management of hepatocellular adenoma: solitary-uncomplicated, multiple and ruptured tumors
Q36063176Massive hemorrhage and infarction complicating focal nodular hyperplasia of the liver
Q36582431Molecular classification of hepatocellular adenomas.
Q57301412Molecular classification of hepatocellular adenomas: impact on clinical practice
Q35603835Oestrogen hormone receptors in focal nodular hyperplasia.
Q77683254Oral contraceptive intake in women with focal nodular hyperplasia of the liver
Q73509722Oral contraceptive use and focal nodular hyperplasia of the liver
Q37577588Outcomes of liver resection in hepatocellular adenoma and focal nodular hyperplasia.
Q88551246Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions
Q43092621Solid focal liver lesions: dynamic and late enhancement patterns with the dual phase contrast agent gadobenate dimeglumine.
Q51043488The clinical course in pediatric solid tumor patients with focal nodular hyperplasia of the liver.
Q42629305The value of laparoscopic liver surgery for solid benign hepatic tumors
Q40045164Tissue sublimation follow transarterial embolization of a follicular nodular hyperplasia of the liver-report of a case
Q81140416Transarterial embolization as a therapeutic option for focal nodular hyperplasia in four patients
Q37558074Transarterial embolization with bleomycin for symptomatic hepatic focal nodular hyperplasia
Q94093775UEG Week 2018 Poster Presentations
Q87620700Use of accumulation images obtained by arterial-phase contrast-enhanced harmonic grayscale ultrasonography to evaluate tumor vessels in focal nodular hyperplasia and other hepatic tumors
Q43042926Use of second generation contrast-enhanced ultrasound in the assessment of focal liver lesions

Search more.